CN104922574A - Xin'an capsule and preparation method thereof - Google Patents

Xin'an capsule and preparation method thereof Download PDF

Info

Publication number
CN104922574A
CN104922574A CN201510285171.8A CN201510285171A CN104922574A CN 104922574 A CN104922574 A CN 104922574A CN 201510285171 A CN201510285171 A CN 201510285171A CN 104922574 A CN104922574 A CN 104922574A
Authority
CN
China
Prior art keywords
parts
radix
fructus
folium
capsule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510285171.8A
Other languages
Chinese (zh)
Inventor
郝瑞华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yu Shi Jindan Chengde Pharmaceutcal Corp Ltd
Original Assignee
Yu Shi Jindan Chengde Pharmaceutcal Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yu Shi Jindan Chengde Pharmaceutcal Corp Ltd filed Critical Yu Shi Jindan Chengde Pharmaceutcal Corp Ltd
Priority to CN201510285171.8A priority Critical patent/CN104922574A/en
Publication of CN104922574A publication Critical patent/CN104922574A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a xin'an capsule and a preparation method thereof. The xin'an capsule mainly comprises the following raw materials: 1500-1800 parts of hawthorn leaves, absolute ethyl alcohol which accounts for 50%-70% of the total weight of the hawthorn leaves, and the like.

Description

A kind of Xinan Capsule and preparation method thereof
Technical field
The invention belongs to technical field of Chinese medicines, be specifically related to a kind of Xinan Capsule and preparation method thereof.
Background technology
Research auxiliary function for lowering blood pressure food object is not be to reduce patients' blood merely, and emphasis is to improve hypertension symptom, promotes the recovery of the heart, brain, kidney, blood vessel pathological change.Modern medicine study proves, doctor trained in Western medicine depressor and traditional Chinese medical science depressor respectively have its pluses and minuses.Western medicine the unresolved pathological factor causing blood pressure to raise, the rising once drug withdrawal blood pressure will rebound very soon, makes patient take medicine all the life; Though the antihypertensive effect of Chinese medicine is not as Western medicine, by its adjustment to internal organs function, improve the pathological factor that causes blood pressure to raise and reach the effect of control blood pressure rising.And the traditional Chinese medical science thinks that Diet cures more than the doctors, the ideal chose of the hyperpietic especially of the medicine with medicine-food two-purpose.Research shows, antihypertensive function food functional component mainly contains flavone (rutin etc.), saponin, unsaturated fatty acid, crude polysaccharides, oligosaccharides, vitamin, potassium magnesium selenium and other trace elements.
At present, market has the health food of kind more than 60 " aided blood pressure-lowering " function, product mostly and the function such as auxiliary antilipemic, improving water flood, antioxidation, auxiliary hyperglycemic arrange in pairs or groups, most aided blood pressure-lowering material also has the function of blood fat reducing.Dosage form, be that the capsule of raw material, tea-drinking, extract electuary are the most common with Chinese herbal medicine.
The development of Chinese medicine, needs innovation, particularly modern society, dietary structure, operating pressure, and living environment contacts more chemical material, the body constitution of people and morbid state, there is change in various degree, the formula of Chinese medicine prescription and Chinese patent medicine, be not exclusively applicable to modern.Indiscriminately imitate ancient prescription simply, indiscriminately imitate Chinese medicine theory, research and production medicine, be not exclusively suitable for the New Times.So according to the modern symptom of modern, studied raising, perfect, be only the development of Chinese medicine.The such as prescription drug of Chinese medicine tonification class, in ancient times, the means of production, ideology are relatively backward, and living standard is quite poor, people's major part is in dreadful conditions of life, and body constitution is weak, and the life-span is short, take tonification medicine, may be very effective, side effect is also obvious not; And modern, living condition improves, and body constitution is also different, indiscriminately imitates traditional tonic to eat, a lot of with regard to problem, connects common mild medicine, eat just got angry less than several days, scorching, produce serious side effects, cannot adhere to eating at all.Like this to treatment and the medical production itself of patient, it is all a kind of waste.Through finding the most of formulating of tradition, the space can improving raising is very big, produces the curative effect of modern and healthy if do not improve to improve according to former side, and the newfound function of Chinese medicine, the scientific utilization of chemical composition, and the development to motherland's medical science are all disadvantageous.The problem that the present invention relates to also is the same, and the Chinese patent medicine that tradition is similar not exclusively adapts to the pathology needs of modern, so improve and research similar drug, significant.
So the problem of several aspects utilizing the active ingredient of Folium Crataegi extract and treatment heart disease to consider, carries out science component, a good medicine will be succeeded in developing.
Summary of the invention
For above-mentioned deficiency of the prior art, the object of the invention is to provide a kind of Xinan Capsule and preparation method thereof
A kind of Xinan Capsule, described capsule raw material weight component proportion is as follows: Folium Crataegi 1500-1800 part, and dehydrated alcohol is the 50%-70% of haw heaf total weight, silkworm compound amino acid, 30 ~ 50 parts, Radix Achyranthis Bidentatae: 40 ~ 80 parts, Radix Glycyrrhizae Preparata: 50 ~ 80 parts, Rhizoma Curculiginis: 40 ~ 90 parts, Herba Cistanches: 30 ~ 100 parts, Rhizoma Panacis Japonici: 40 ~ 70 parts, Fructus Schisandrae Chinensis: 9 ~ 15 parts, Cornu Cervi Pantotrichum: 10 ~ 20 parts, Pyritum: 9 ~ 24 parts, Fructus Hordei Germinatus 100-150 part, Flos Chrysanthemi Indici 50-100 part, Fructus Gardeniae 100-150 part, Semen Cassiae 150-200 part, Radix Scutellariae 120-160 part, Fructus Lycii 80-120 part, Folium Kaki 140-180 part, Radix Puerariae 150-200 part, Spica Prunellae 50-100 part, Ganoderma 100-150 part, Radix Notoginseng 90-130 part, Radix Bupleuri 100-150 part, Folium Apocyni Veneti 140-180 part, Stigma Maydis 50-100 part, Radix Platycodonis 120-160 part, Folium Nelumbinis 100-150 part, Radix Polygoni Multiflori 100-200 part, Fructus Alpiniae Oxyphyllae 100-200 part, Cortex Moutan 100-200 part, Semen Nelumbinis 100-200 part.
Preferably, described capsule raw material weight component proportion is as follows: Folium Crataegi 1500 parts, and dehydrated alcohol is 50% of haw heaf total weight, silkworm compound amino acid, 30 parts, Radix Achyranthis Bidentatae: 40 parts; Radix Glycyrrhizae Preparata: 50 parts; Rhizoma Curculiginis: 40 parts; Herba Cistanches: 30 parts; Rhizoma Panacis Japonici: 40 parts; Fructus Schisandrae Chinensis: 9 parts; Cornu Cervi Pantotrichum: 10 parts; Pyritum: 9 parts; Fructus Hordei Germinatus 100 parts, Flos Chrysanthemi Indici 50 parts, Fructus Gardeniae 100 parts, Semen Cassiae 150 parts, Radix Scutellariae 120 parts, Fructus Lycii 80 parts, Folium Kaki 140 parts, Radix Puerariae 150 parts, Spica Prunellae 50 parts, Ganoderma 100 parts, Radix Notoginseng 90 parts, Radix Bupleuri 100 parts, Folium Apocyni Veneti 140 parts, Stigma Maydis 50 parts, Radix Platycodonis 120 parts, 100 parts, Folium Nelumbinis, the Radix Polygoni Multiflori 100 parts, Fructus Alpiniae Oxyphyllae 100 parts, Cortex Moutan 100 parts, 100 parts, Semen Nelumbinis.
Preferably, described capsule raw material weight component proportion is as follows: Folium Crataegi 1800 parts, and dehydrated alcohol is 70% of haw heaf total weight, silkworm compound amino acid 50 parts, Radix Achyranthis Bidentatae 80 parts; Radix Glycyrrhizae Preparata 80 parts; Rhizoma Curculiginis 90 parts; Herba Cistanches 100 parts; Rhizoma Panacis Japonici 70 parts; Fructus Schisandrae Chinensis 15 parts; 20 parts, Cornu Cervi Pantotrichum; Pyritum 24 parts; Fructus Hordei Germinatus 150 parts, Flos Chrysanthemi Indici 100 parts, Fructus Gardeniae 150 parts, Semen Cassiae 200 parts, Radix Scutellariae 160 parts, Fructus Lycii 120 parts, Folium Kaki 180 parts, Radix Puerariae 200 parts, Spica Prunellae 100 parts, Ganoderma 150 parts, Radix Notoginseng 130 parts, Radix Bupleuri 150 parts, Folium Apocyni Veneti 180 parts, Stigma Maydis 100 parts, Radix Platycodonis 160 parts, 150 parts, Folium Nelumbinis, the Radix Polygoni Multiflori 200 parts, Fructus Alpiniae Oxyphyllae 200 parts, Cortex Moutan 200 parts, 200 parts, Semen Nelumbinis.
Preferably, described capsule raw material weight component proportion is as follows: Folium Crataegi 1500 parts, and dehydrated alcohol is 70% of haw heaf total weight, silkworm compound amino acid 45 parts, Radix Achyranthis Bidentatae 56 parts; Radix Glycyrrhizae Preparata 65 parts; Rhizoma Curculiginis 70 parts; Herba Cistanches 45 parts; Rhizoma Panacis Japonici 55 parts; Fructus Schisandrae Chinensis 13 parts; 15 parts, Cornu Cervi Pantotrichum; Pyritum 20 parts; Fructus Hordei Germinatus 130 parts, Flos Chrysanthemi Indici 58 parts, Fructus Gardeniae 118 parts, Semen Cassiae 168 parts, Radix Scutellariae 156 parts, Fructus Lycii 88 parts, Folium Kaki 168 parts, Radix Puerariae 188 parts, Spica Prunellae 88 parts, Ganoderma 116 parts, Radix Notoginseng 120 parts, Radix Bupleuri 130 parts, Folium Apocyni Veneti 150 parts, Stigma Maydis 80 parts, Radix Platycodonis 158 parts, 120 parts, Folium Nelumbinis, the Radix Polygoni Multiflori 180 parts, Fructus Alpiniae Oxyphyllae 180 parts, Cortex Moutan 150 parts, 160 parts, Semen Nelumbinis.
The preparation method of described Xinan Capsule, the step of described method comprises:
According to raw material components proportioning raw materials weighing, be pulverized and mixed by solid material evenly, add dehydrated alcohol, reflux, extract, filter, reclaim ethanol, be condensed into cream, ovendry power is broken into fine powder, measures content, makes granule, dry, encapsulated, to obtain final product.
beneficial effect:
expansion coronary vasodilator, improves blood supply of cardiac muscle amount, reduces blood fat.Be used for the treatment of coronary heart disease, angina pectoris, chest distress and palpitation symptoms, hypertension etc.
Detailed description of the invention
embodiment 1
Described capsule raw material weight component proportion is as follows: Folium Crataegi 1500 parts, and dehydrated alcohol is 50% of haw heaf total weight, silkworm compound amino acid, 30 parts, Radix Achyranthis Bidentatae: 40 parts; Radix Glycyrrhizae Preparata: 50 parts; Rhizoma Curculiginis: 40 parts; Herba Cistanches: 30 parts; Rhizoma Panacis Japonici: 40 parts; Fructus Schisandrae Chinensis: 9 parts; Cornu Cervi Pantotrichum: 10 parts; Pyritum: 9 parts; Fructus Hordei Germinatus 100 parts, Flos Chrysanthemi Indici 50 parts, Fructus Gardeniae 100 parts, Semen Cassiae 150 parts, Radix Scutellariae 120 parts, Fructus Lycii 80 parts, Folium Kaki 140 parts, Radix Puerariae 150 parts, Spica Prunellae 50 parts, Ganoderma 100 parts, Radix Notoginseng 90 parts, Radix Bupleuri 100 parts, Folium Apocyni Veneti 140 parts, Stigma Maydis 50 parts, Radix Platycodonis 120 parts, 100 parts, Folium Nelumbinis, the Radix Polygoni Multiflori 100 parts, Fructus Alpiniae Oxyphyllae 100 parts, Cortex Moutan 100 parts, 100 parts, Semen Nelumbinis.
embodiment 2
Described capsule raw material weight component proportion is as follows: Folium Crataegi 1800 parts, and dehydrated alcohol is 70% of haw heaf total weight, silkworm compound amino acid 50 parts, Radix Achyranthis Bidentatae 80 parts; Radix Glycyrrhizae Preparata 80 parts; Rhizoma Curculiginis 90 parts; Herba Cistanches 100 parts; Rhizoma Panacis Japonici 70 parts; Fructus Schisandrae Chinensis 15 parts; 20 parts, Cornu Cervi Pantotrichum; Pyritum 24 parts; Fructus Hordei Germinatus 150 parts, Flos Chrysanthemi Indici 100 parts, Fructus Gardeniae 150 parts, Semen Cassiae 200 parts, Radix Scutellariae 160 parts, Fructus Lycii 120 parts, Folium Kaki 180 parts, Radix Puerariae 200 parts, Spica Prunellae 100 parts, Ganoderma 150 parts, Radix Notoginseng 130 parts, Radix Bupleuri 150 parts, Folium Apocyni Veneti 180 parts, Stigma Maydis 100 parts, Radix Platycodonis 160 parts, 150 parts, Folium Nelumbinis, the Radix Polygoni Multiflori 200 parts, Fructus Alpiniae Oxyphyllae 200 parts, Cortex Moutan 200 parts, 200 parts, Semen Nelumbinis.
embodiment 3
Described capsule raw material weight component proportion is as follows: Folium Crataegi 1500 parts, and dehydrated alcohol is 70% of haw heaf total weight, silkworm compound amino acid 45 parts, Radix Achyranthis Bidentatae 56 parts; Radix Glycyrrhizae Preparata 65 parts; Rhizoma Curculiginis 70 parts; Herba Cistanches 45 parts; Rhizoma Panacis Japonici 55 parts; Fructus Schisandrae Chinensis 13 parts; 15 parts, Cornu Cervi Pantotrichum; Pyritum 20 parts; Fructus Hordei Germinatus 130 parts, Flos Chrysanthemi Indici 58 parts, Fructus Gardeniae 118 parts, Semen Cassiae 168 parts, Radix Scutellariae 156 parts, Fructus Lycii 88 parts, Folium Kaki 168 parts, Radix Puerariae 188 parts, Spica Prunellae 88 parts, Ganoderma 116 parts, Radix Notoginseng 120 parts, Radix Bupleuri 130 parts, Folium Apocyni Veneti 150 parts, Stigma Maydis 80 parts, Radix Platycodonis 158 parts, 120 parts, Folium Nelumbinis, the Radix Polygoni Multiflori 180 parts, Fructus Alpiniae Oxyphyllae 180 parts, Cortex Moutan 150 parts, 160 parts, Semen Nelumbinis.
Last it is noted that obviously, above-described embodiment is only for example of the present invention is clearly described, and the restriction not to embodiment.For those of ordinary skill in the field, can also make other changes in different forms on the basis of the above description.Here exhaustive without the need to also giving all embodiments.And thus the apparent change of amplifying out or variation be still among protection scope of the present invention.

Claims (5)

1. an Xinan Capsule, is characterized in that, described capsule raw material weight component proportion is as follows: Folium Crataegi 1500-1800 part, and dehydrated alcohol is the 50%-70% of haw heaf total weight, silkworm compound amino acid, 30 ~ 50 parts, Radix Achyranthis Bidentatae: 40 ~ 80 parts, Radix Glycyrrhizae Preparata: 50 ~ 80 parts, Rhizoma Curculiginis: 40 ~ 90 parts, Herba Cistanches: 30 ~ 100 parts, Rhizoma Panacis Japonici: 40 ~ 70 parts, Fructus Schisandrae Chinensis: 9 ~ 15 parts, Cornu Cervi Pantotrichum: 10 ~ 20 parts, Pyritum: 9 ~ 24 parts, Fructus Hordei Germinatus 100-150 part, Flos Chrysanthemi Indici 50-100 part, Fructus Gardeniae 100-150 part, Semen Cassiae 150-200 part, Radix Scutellariae 120-160 part, Fructus Lycii 80-120 part, Folium Kaki 140-180 part, Radix Puerariae 150-200 part, Spica Prunellae 50-100 part, Ganoderma 100-150 part, Radix Notoginseng 90-130 part, Radix Bupleuri 100-150 part, Folium Apocyni Veneti 140-180 part, Stigma Maydis 50-100 part, Radix Platycodonis 120-160 part, Folium Nelumbinis 100-150 part, Radix Polygoni Multiflori 100-200 part, Fructus Alpiniae Oxyphyllae 100-200 part, Cortex Moutan 100-200 part, Semen Nelumbinis 100-200 part.
2. Xinan Capsule according to claim 1, is characterized in that, described capsule raw material weight component proportion is as follows: Folium Crataegi 1500 parts, and dehydrated alcohol is 50% of haw heaf total weight, silkworm compound amino acid, 30 parts, Radix Achyranthis Bidentatae: 40 parts; Radix Glycyrrhizae Preparata: 50 parts; Rhizoma Curculiginis: 40 parts; Herba Cistanches: 30 parts; Rhizoma Panacis Japonici: 40 parts; Fructus Schisandrae Chinensis: 9 parts; Cornu Cervi Pantotrichum: 10 parts; Pyritum: 9 parts; Fructus Hordei Germinatus 100 parts, Flos Chrysanthemi Indici 50 parts, Fructus Gardeniae 100 parts, Semen Cassiae 150 parts, Radix Scutellariae 120 parts, Fructus Lycii 80 parts, Folium Kaki 140 parts, Radix Puerariae 150 parts, Spica Prunellae 50 parts, Ganoderma 100 parts, Radix Notoginseng 90 parts, Radix Bupleuri 100 parts, Folium Apocyni Veneti 140 parts, Stigma Maydis 50 parts, Radix Platycodonis 120 parts, 100 parts, Folium Nelumbinis, the Radix Polygoni Multiflori 100 parts, Fructus Alpiniae Oxyphyllae 100 parts, Cortex Moutan 100 parts, 100 parts, Semen Nelumbinis.
3. Xinan Capsule according to claim 1, is characterized in that, described capsule raw material weight component proportion is as follows: Folium Crataegi 1800 parts, and dehydrated alcohol is 70% of haw heaf total weight, silkworm compound amino acid 50 parts, Radix Achyranthis Bidentatae 80 parts; Radix Glycyrrhizae Preparata 80 parts; Rhizoma Curculiginis 90 parts; Herba Cistanches 100 parts; Rhizoma Panacis Japonici 70 parts; Fructus Schisandrae Chinensis 15 parts; 20 parts, Cornu Cervi Pantotrichum; Pyritum 24 parts; Fructus Hordei Germinatus 150 parts, Flos Chrysanthemi Indici 100 parts, Fructus Gardeniae 150 parts, Semen Cassiae 200 parts, Radix Scutellariae 160 parts, Fructus Lycii 120 parts, Folium Kaki 180 parts, Radix Puerariae 200 parts, Spica Prunellae 100 parts, Ganoderma 150 parts, Radix Notoginseng 130 parts, Radix Bupleuri 150 parts, Folium Apocyni Veneti 180 parts, Stigma Maydis 100 parts, Radix Platycodonis 160 parts, 150 parts, Folium Nelumbinis, the Radix Polygoni Multiflori 200 parts, Fructus Alpiniae Oxyphyllae 200 parts, Cortex Moutan 200 parts, 200 parts, Semen Nelumbinis.
4. Xinan Capsule according to claim 1, is characterized in that, described capsule raw material weight component proportion is as follows: Folium Crataegi 1500 parts, and dehydrated alcohol is 70% of haw heaf total weight, silkworm compound amino acid 45 parts, Radix Achyranthis Bidentatae 56 parts; Radix Glycyrrhizae Preparata 65 parts; Rhizoma Curculiginis 70 parts; Herba Cistanches 45 parts; Rhizoma Panacis Japonici 55 parts; Fructus Schisandrae Chinensis 13 parts; 15 parts, Cornu Cervi Pantotrichum; Pyritum 20 parts; Fructus Hordei Germinatus 130 parts, Flos Chrysanthemi Indici 58 parts, Fructus Gardeniae 118 parts, Semen Cassiae 168 parts, Radix Scutellariae 156 parts, Fructus Lycii 88 parts, Folium Kaki 168 parts, Radix Puerariae 188 parts, Spica Prunellae 88 parts, Ganoderma 116 parts, Radix Notoginseng 120 parts, Radix Bupleuri 130 parts, Folium Apocyni Veneti 150 parts, Stigma Maydis 80 parts, Radix Platycodonis 158 parts, 120 parts, Folium Nelumbinis, the Radix Polygoni Multiflori 180 parts, Fructus Alpiniae Oxyphyllae 180 parts, Cortex Moutan 150 parts, 160 parts, Semen Nelumbinis.
5. the preparation method of Xinan Capsule described in claim 1-4 any one, is characterized in that, the step of described method comprises:
According to raw material components proportioning raw materials weighing, be pulverized and mixed by solid material evenly, add dehydrated alcohol, reflux, extract, filter, reclaim ethanol, be condensed into cream, ovendry power is broken into fine powder, measures content, makes granule, dry, encapsulated, to obtain final product.
CN201510285171.8A 2015-05-29 2015-05-29 Xin'an capsule and preparation method thereof Pending CN104922574A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510285171.8A CN104922574A (en) 2015-05-29 2015-05-29 Xin'an capsule and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510285171.8A CN104922574A (en) 2015-05-29 2015-05-29 Xin'an capsule and preparation method thereof

Publications (1)

Publication Number Publication Date
CN104922574A true CN104922574A (en) 2015-09-23

Family

ID=54110222

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510285171.8A Pending CN104922574A (en) 2015-05-29 2015-05-29 Xin'an capsule and preparation method thereof

Country Status (1)

Country Link
CN (1) CN104922574A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105311492A (en) * 2015-11-30 2016-02-10 王平平 Medicine for treating coronary atherosclerotic heart disease
CN106359752A (en) * 2016-08-30 2017-02-01 江苏中兴药业有限公司 Four-leaf health-care tea and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103623248A (en) * 2013-11-29 2014-03-12 高鑫 Traditional Chinese medicinal composition for reducing blood pressure
CN103656303A (en) * 2013-12-17 2014-03-26 青岛中科菲力工程技术研发有限公司 Traditional Chinese medicine capsule with function of reducing blood pressure and preparation method of traditional Chinese medicine capsule

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103623248A (en) * 2013-11-29 2014-03-12 高鑫 Traditional Chinese medicinal composition for reducing blood pressure
CN103656303A (en) * 2013-12-17 2014-03-26 青岛中科菲力工程技术研发有限公司 Traditional Chinese medicine capsule with function of reducing blood pressure and preparation method of traditional Chinese medicine capsule

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
周鲁等: "治疗高血压常用中药复方用药规律分析", 《中医杂志》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105311492A (en) * 2015-11-30 2016-02-10 王平平 Medicine for treating coronary atherosclerotic heart disease
CN106359752A (en) * 2016-08-30 2017-02-01 江苏中兴药业有限公司 Four-leaf health-care tea and preparation method thereof

Similar Documents

Publication Publication Date Title
CN101513437B (en) Antifatigue Chinese pharmaceutical composition and preparation method thereof
CN103877263B (en) A kind of antifatigue health preparation of the compound Chinese medicine such as red ginseng, maca, green-tea extract (theanine)
CN103169895A (en) Traditional Chinese medicine used for losing weight
CN102940801A (en) Traditional Chinese medicine composition for treating hypertension
CN106562413A (en) Oral thick paste for immunity enhancement and preparation method thereof
CN102172385A (en) Chinese medicinal preparation with effects of enhancing immunity, lowering blood sugar and lowering blood fat
CN103859369A (en) Health-preserving health food formula beneficial for beautifying and enlarging breasts and preparation method thereof
CN101537120A (en) Health care product for maintaining beauty and lengthening life
CN106138869A (en) A kind for the treatment of four high Chinese medicine compositions and preparation method thereof
CN103734767B (en) Health-care food
CN104922574A (en) Xin'an capsule and preparation method thereof
CN103705860B (en) A kind of Chinese medicine composition for the treatment of infant jaundice and preparation method thereof
CN103860773A (en) Traditional Chinese medicine composition for treating myocardial ischemia and preparation method thereof
CN103725587A (en) Sealwort and hawthorn vinegar and production method thereof
CN107320631A (en) A kind of anti-fatigue Chinese medicinal composition and preparation method thereof
CN104257839B (en) A kind of Chinese medicine composition with hypoglycemic protection blood vessel endothelium effect and preparation method thereof
CN103263582A (en) Weight losing prescription
CN105362630A (en) Climacteric syndrome treatment pharmaceutical composition and preparation method thereof
CN103054073B (en) Beautifying fish scale jelly and preparation method thereof
CN105638961A (en) Dark green tea composition with ramie leaves and preparation method thereof
CN101987188B (en) Biological Chinese patent drug for preventing and treating hyperlipoidemia
CN110279809A (en) A kind of composition of enriching yin and nourishing kidney and the preparation method and application thereof
CN1060349C (en) Menstruation-regulating and speckle-removing capsule and preparation thereof
CN110522798A (en) A kind of compound preparation and preparation method thereof curing mainly coronary heart disease
CN104857342A (en) Hawthorn-rose capsule and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20150923